ZA991233B - Use of thiadiazolo pyridine derivatives. - Google Patents
Use of thiadiazolo pyridine derivatives.Info
- Publication number
- ZA991233B ZA991233B ZA9901233A ZA991233A ZA991233B ZA 991233 B ZA991233 B ZA 991233B ZA 9901233 A ZA9901233 A ZA 9901233A ZA 991233 A ZA991233 A ZA 991233A ZA 991233 B ZA991233 B ZA 991233B
- Authority
- ZA
- South Africa
- Prior art keywords
- thiadiazolo
- pyridine derivatives
- pyridine
- derivatives
- thiadiazolo pyridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98102675 | 1998-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA991233B true ZA991233B (en) | 1999-08-17 |
Family
ID=8231426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9901233A ZA991233B (en) | 1998-02-17 | 1999-02-16 | Use of thiadiazolo pyridine derivatives. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6326378B1 (de) |
EP (1) | EP1054669B9 (de) |
JP (1) | JP3585838B2 (de) |
AR (1) | AR015518A1 (de) |
AU (1) | AU2926099A (de) |
CA (1) | CA2318237A1 (de) |
DE (2) | DE69909592D1 (de) |
ES (1) | ES2203086T3 (de) |
WO (1) | WO1999042089A2 (de) |
ZA (1) | ZA991233B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1193261A1 (de) * | 2000-10-02 | 2002-04-03 | Warner-Lambert Company | Thiadiazole und ihre Verwendung als Phosphodiesterase-7 Inhibitoren |
EP1348433A1 (de) * | 2002-03-28 | 2003-10-01 | Warner-Lambert Company LLC | Thiazol-5-yl-imine als PDE7-Inhibitoren |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US7034052B2 (en) * | 2003-03-12 | 2006-04-25 | Celgene Corporation | 7-Amido-isoindolyl compounds and their pharmaceutical uses |
US7564337B2 (en) | 2005-03-03 | 2009-07-21 | Littelfuse, Inc. | Thermally decoupling fuse holder and assembly |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60246389A (ja) * | 1984-05-22 | 1985-12-06 | Nippon Soda Co Ltd | 2−スルホニルイミノ−2H−1,2,4−チアジアゾロ〔2,3−a〕ピリジン誘導体及びその製造法 |
DE4131579A1 (de) * | 1991-09-23 | 1993-03-25 | Boehringer Mannheim Gmbh | Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel |
-
1999
- 1999-02-11 JP JP2000532106A patent/JP3585838B2/ja not_active Expired - Fee Related
- 1999-02-11 EP EP99910217A patent/EP1054669B9/de not_active Expired - Lifetime
- 1999-02-11 US US09/622,325 patent/US6326378B1/en not_active Expired - Fee Related
- 1999-02-11 WO PCT/EP1999/000886 patent/WO1999042089A2/en active IP Right Grant
- 1999-02-11 DE DE69909592A patent/DE69909592D1/de not_active Expired - Fee Related
- 1999-02-11 ES ES99910217T patent/ES2203086T3/es not_active Expired - Lifetime
- 1999-02-11 AU AU29260/99A patent/AU2926099A/en not_active Abandoned
- 1999-02-11 DE DE69909592T patent/DE69909592T4/de not_active Expired - Lifetime
- 1999-02-11 CA CA002318237A patent/CA2318237A1/en not_active Abandoned
- 1999-02-16 ZA ZA9901233A patent/ZA991233B/xx unknown
- 1999-02-16 AR ARP990100622A patent/AR015518A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP3585838B2 (ja) | 2004-11-04 |
DE69909592T4 (de) | 2005-03-24 |
AU2926099A (en) | 1999-09-06 |
JP2002503688A (ja) | 2002-02-05 |
EP1054669B1 (de) | 2003-07-16 |
EP1054669A2 (de) | 2000-11-29 |
WO1999042089A3 (en) | 1999-10-14 |
WO1999042089A9 (en) | 1999-10-28 |
CA2318237A1 (en) | 1999-08-26 |
EP1054669B9 (de) | 2004-09-15 |
ES2203086T3 (es) | 2004-04-01 |
AR015518A1 (es) | 2001-05-02 |
US6326378B1 (en) | 2001-12-04 |
WO1999042089A2 (en) | 1999-08-26 |
DE69909592D1 (de) | 2003-08-21 |
DE69909592T2 (de) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036981A1 (en) | Imidazo pyridine derivatives which inhibit gastricacid secretion. | |
CZ20011556A3 (cs) | Pyrazolopyridinové deriváty | |
PL343865A1 (en) | Pyridine derivatives | |
HK1042295A1 (zh) | 1h-咪唑並吡啶衍生物 | |
HK1032005A1 (en) | Polymeric derivatives of camptothecins. | |
HK1022310A1 (en) | Benzosulfone derivatives | |
GB9910384D0 (en) | Alpha-ketoamide derivatives | |
ZA9811925B (en) | Thiazole derivatives. | |
AU5065999A (en) | Naphthyridine derivatives | |
PL342060A1 (en) | Derivatives of 1,3,4-oxadiaxolone | |
ZA991550B (en) | Cyclohexanediole derivatives. | |
EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
DE69912590D1 (de) | Pde-iv-hemmende pyridin-derivate | |
ZA991233B (en) | Use of thiadiazolo pyridine derivatives. | |
GB9827729D0 (en) | Thieno-indole derivatives | |
AU2640999A (en) | 1-azaindolizine derivatives | |
EP1061912A4 (de) | Phenanthrofuranderivate | |
ZA9811923B (en) | Thiazole derivatives. | |
IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
GB9706923D0 (en) | Pyridine derivatives | |
HK1042478A1 (zh) | 2-氧代-2h-喹啉衍生物 | |
PL341713A1 (en) | Derivatives of spiropiperidine | |
AU1684300A (en) | Cyclohexylpiperidine derivatives | |
AU1861600A (en) | Thiochromanoylpyrazolone derivatives | |
AU2852199A (en) | Benzothiazolone-7-sulfonamide derivatives |